Overview

The Effect of Obesity in Dexmedetomidine Metabolic Clearance

Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study the effect of obesity in dexmedetomidine pharmacokinetics and pharmacodynamic profile.
Phase:
Phase 4
Details
Lead Sponsor:
Pontificia Universidad Catolica de Chile
Treatments:
Dexmedetomidine